Thursday, March 28, 2024

IMSS bought medications from firm linked to board member

The Mexican Social Security Institute (IMSS) purchased medications worth more than half a billion pesos between 2015 and 2018 from a company owned by the son of one of its board members, according to an anti-graft group.

Mexicans Against Corruption and Impunity (MCCI) said it obtained documents that show that the pharmaceutical company Marzam received contracts in that period for more than 526 million pesos (US $27.1 million at today’s exchange rate).

Luis Doporto Alejandre, son of Héctor Doporto Ramírez, purchased Marzam in 2015.

For the next three years, the company’s sales to IMSS, which operates public hospitals and health care clinics, were more than five times greater than its sales to the same government organization in the much longer period between 2002 and 2014.

Héctor Doporto has sat on the IMSS board since 2010.

MCCI said in its investigation report that as the value of Marzam’s contracts with IMSS multiplied, the company was under investigation by federal authorities for financial crimes.

Luis Doporto Alejandre told MCCI that although his father sat on the IMMS board, he was a substitute rather than a permanent member and never involved in purchasing processes, “least of all for medications and dressing materials.”

Source: El Financiero (sp) 

The container ship the Dali crashing into the Francis Scott Key bridge in Baltimore

AMLO confirms 1 Mexican rescued, 2 missing after Baltimore bridge collapse

0
Mexico's President López Obrador confirmed Wednesday morning that the Mexican nationals were working on the bridge when it collapsed Tuesday.
Firefighters in Veracruz

1,000 firefighters combat blazes in Veracruz as wildfires spike nationwide

0
The wildfires in the mountainous central region of the state started on Saturday and have yet to be fully controlled.
A worker sprays a field with a chemical

Mexico postpones glyphosate ban citing lack of available alternatives

1
The World Health Organization classifies the controversial herbicide as a “probable carcinogen.”